跳至主要内容
临床试验/ACTRN12614000473662
ACTRN12614000473662尚未招募未知

Double-blinded Prospective Randomised Controlled Trial of Split Skin Graft Donor-Site Dressing: A Clinical Comparative Trial of a Novel Transforming Powder Dressing, Altrazeal (TM) and Calcium Sodium Alginate, Kaltostat (TM) Dressing.

Plastic and Reconstructive Surgery Department, Monash Health0 个研究点目标入组 60 人开始时间: 2014年5月6日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Participants will be adults (aged 18 years or older) undergoing split skin grafting at Dandenong Hospital. To be included, patients will have a traumatic wound or large skin neoplasms in lower limbs requiring excision leaving a skin defect of at least 10cm2.

排除标准

  • 1.Patient unable to provide consent due to cognitive impairment (e.g. intellectual disability, dementia, delirium, or unconscious).
  • 2.Patients with known sensitivity or allergies to either Calcium Sodium Alginate, Kaltostat(TM) or Novel Transforming Powder, Altrazeal (TM) dressings or its components.
  • 3.Pregnant women.

研究者

发起方
Plastic and Reconstructive Surgery Department, Monash Health

相似试验

Double-blinded Prospective Randomised Controlled... | 临床试验